חובות לטווח קצר של החברה: Checkpoint Therapeutics, Inc. (CKPT)

The price characteristics for Checkpoint Therapeutics (CKPT) on the GURU.Markets platform are 0.00, which accompanies the activities of Checkpoint Therapeutics (CKPT). The business relies on a virtual management model, attracting experts through option programs and outsourced development. Checkpoint Therapeutics (CKPT) diversifies risks by creating targeted drugs for lung and skin therapy. Currently, the antibody ecosystem is facing FDA delays due to external manufacturing audits, which temporarily limits commercialization.

The efficiency of outsourcing synthesis and testing at Checkpoint Therapeutics (CKPT) depends directly on the liquidity available to pay external vendors. This metric measures the daily load of obligations for up to one year, determining the balance between expansion and the risk of a cash crunch, which allows for an assessment of the issuer's financial stability through short-term borrowing volume.